Pancreatic Cell News Volume 12.13 | Apr 6 2021

    0
    39







    2021-04-6 | PACN 12.13


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 12.13 – 6 April, 2021
    TOP STORY

    Single-Cell Chromatin Accessibility Identifies Pancreatic Islet Cell Type-and State-Specific Regulatory Programs of Diabetes Risk

    Researchers observed state-specific enrichment of fasting glucose and type 2 diabetes genome-wide association studies for beta cells and enrichment for other endocrine cell types.
    [Nature Genetics]

    Abstract

    Register for a recorded organoid panel discussion moderated by Dr. James Wells
    PUBLICATIONSRanked by the impact factor of the journal

    Coordinated Interactions between Endothelial Cells and Macrophages in the Islet Microenvironment Promote β Cell Regeneration

    The authors showed that proliferative endothelial cells modulated macrophage (MΦ) infiltration and phenotype during β cell loss, and recruited MΦs were essential for β cell recovery.
    [npj Regenerative Medicine]

    Full Article

    Insulin-Positive Ductal Cells Do Not Migrate Into Preexisting Islets during Pregnancy

    Researchers used a cell-tagging dye, CFDA-SE, to permanently label pancreatic duct cells through an intraductal infusion technique.
    [Experimental and Molecular Medicine]

    Full Article

    BCL3 Couples Cancer Stem Cell Enrichment with Pancreatic Cancer Molecular Subtypes

    Scientists demonstrated that B-cell CLL/lymphoma 3 (Bcl3) impacted pancreatic carcinogenesis by restraining cancer stem cell expansion and by curtailing an aggressive and metastatic tumor burden in PDAC across species.
    [Gastroenterology]

    AbstractGraphical Abstract

    Lipocalin 2 Mediates Appetite Suppression during Pancreatic Cancer Cachexia

    Investigators demonstrated that Lipocalin 2 (LCN2) was robustly upregulated in murine models of pancreatic cancer, its expression was associated with reduced food consumption, and Lcn2 deletion was protective from cachexia-anorexia.
    [Nature Communications]

    Full Article

    Regulator of Calcineurin 1 Gene Isoform 4 in Pancreatic Ductal Adenocarcinoma Regulates the Progression of Tumor Cells

    Researchers report a novel role of regulator of calcineurin 1, isoform 4 (RCAN1.4) in regulating PDAC progression. They demonstrated that RCAN1.4 expression was decreased significantly in PDAC tissues compared with that in para-cancerous tissues, and correlated with poor prognosis of patients with pancreatic cancer.
    [Oncogene]

    Full Article

    MIB1 Upregulates IQGAP1 and Promotes Pancreatic Cancer Progression by Inducing ST7 Degradation

    Scientists confirmed that mind bomb 1 (MIB1) expression was elevated in pancreatic cancer tissues and that high levels of MIB associated with unfavorable prognosis. Overexpression of MIB1 enhanced proliferation and invasion of pancreatic cancer cells both in vitro and in vivo.
    [Molecular Oncology]

    Abstract

    MiR-30d Suppresses Proliferation and Invasiveness of Pancreatic Cancer by Targeting the SOX4/PI3K-AKT Axis and Predicts Poor Outcome

    The role of miR-30d in the proliferation and metastasis of pancreatic cancer cells was determined using in vitro and in vivo assays.
    [Cell Death & Disease]

    Full Article

    AXL is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer

    The authors used single cell RNA sequencing to reveal that AXL was expressed highly in tumor cells that had a mesenchymal-like phenotype and that AXL expression correlated with classic markers of epithelial to mesenchymal transition.
    [Molecular Cancer Research]

    Abstract

    Plasma Biomarkers for Prediction of Early Tumor Recurrence after Resection of Pancreatic Ductal Adenocarcinoma

    Scientists identified preoperative plasma protein biomarkers with the potential to predict early recurrence after resection of PDAC.
    [Scientific Reports]

    Full Article

    LncRNA FGD5-AS1 Accelerates Cell Proliferation in Pancreatic Cancer by Regulating miR-520a-3p/KIAA1522 Axis

    FGD5-AS1 accelerated cell proliferation and migration via sponging miR-520a-3p and upregulating KIAA1522.
    [Cancer Biology & Therapy]

    Abstract

    Explore scientific events this April with the Science Events Calendar.
    REVIEWS

    Insulin and Insulin Analogs as Antidiabetic Therapy: A Perspective from Clinical Trials

    The authors discuss the development of the most widely available insulin preparations and provide evidence-based insight into their use in clinical practice.
    [Cell Metabolism]

    Full Article

    Human Pluripotent Stem Cell-Derived Insulin-Producing Cells: A Regenerative Medicine Perspective

    Investigators discuss current challenges surrounding the generation, delivery, and engraftment of stem cell-derived islet-like cells, along with strategies to induce durable tolerance to grafted cells, with an eye toward a functional cellular-based therapy enabling insulin independence for patients with diabetes.
    [Cell Metabolism]

    Full Article

    INDUSTRY AND POLICY NEWS

    Bluestar Genomics Receives FDA Breakthrough Device Designation for First-of-Its-Kind Pancreatic Cancer Screening Test

    Bluestar Genomics announced it has received FDA Breakthrough Device designation for its proprietary noninvasive pancreatic cancer detection test in patients with new-onset diabetes.
    [Bluestar Genomics (Business Wire, Inc.)]

    Press Release

    Celon Pharma Announces CPL’280, Second Generation Oral GPR40 Agonist, Meets Primary Endpoint in Phase I Trial

    Celon Pharma S.A. announced the successful completion of a Phase I trial of its second generation GPR40 agonist, CPL’280. This agent is in development for the treatment of Diabetes and Diabetic Neuropathy and met its primary endpoint, with no adverse safety signals detected.
    [Celon Pharma S.A. (Globe Newswire, Inc)]

    Press Release

    FEATURED EVENT

    ISSCR: Stem Cells – From Basic Science to Clinical Translation

    October 27 – 29, 2021
    Tokyo, Japan

    > See All Events

    JOB OPPORTUNITIES

    Research Technician Positions – Functional Genomics

    Cold Spring Harbor Laboratory – Cold Spring Harbor, New York, United States

    Postdoctoral Positions – Endocrinology, Nutrition and Metabolism

    Rutgers University – New Brunswick, New Jersey, United States

    Medicinal Chemist – Muscle-Wasting, Neurodegeneration, and Oncology

    Almac – Belfast, Ireland

    Postdoctoral Fellowship – Diabetes Research

    University of Michigan – Ann Arbor, Michigan, United States

    Faculty and Postdoctoral Positions – Stem Cells and Cancer

    Shanghai Jiao Tong University School of Medicine- Shanghai, China

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter